A Multicenter Randomized, Double-Blind, Controlled Study to Evaluate Safety, Tolerability and Preliminary Efficacy of Two Capsaicin Concentration Variations of NGX-1998 (10% or 20% w/w) in Subjects With Postherpetic Neuralgia (PHN).

Trial Profile

A Multicenter Randomized, Double-Blind, Controlled Study to Evaluate Safety, Tolerability and Preliminary Efficacy of Two Capsaicin Concentration Variations of NGX-1998 (10% or 20% w/w) in Subjects With Postherpetic Neuralgia (PHN).

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Sep 2012

At a glance

  • Drugs Capsaicin (Primary)
  • Indications Postherpetic neuralgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Aug 2012 Further results were reported at the 14th World Congress on Pain, according to a NeurogesX media release.
    • 16 Jul 2012 Further results will be reported at the 14th World Congress on Pain, according to a NeurogesX media release.
    • 19 May 2012 Results presented at the 31st Annual Scientific Meeting of the American Pain Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top